HIGHLY EFFECTIVE TREATMENT
Discover SPRAVATO®
New Hope for Treatment-Resistant Depression
ABOUT SPRAVATO®
What is SPRAVATO®?
SPRAVATO® is a safe, non-invasive prescription nasal spray designed to treat adults with major depressive disorder (MDD) who have not found relief with other antidepressant treatments. Unlike traditional antidepressants, SPRAVATO® can work quickly, sometimes within hours or days, offering a new avenue of hope for those struggling with treatment-resistant depression.
How Does SPRAVATO® Work?
SPRAVATO® targets the NMDA receptor in the brain. This mechanism is believed to help restore synaptic connections in brain cells involved in mood regulation. By acting on a different pathway than conventional antidepressants, SPRAVATO® provides rapid relief and can improve symptoms where other treatments have failed.
Inquire Now
Why Choose SPRAVATO®?
Rapid Onset of Action: SPRAVATO® can reduce depressive symptoms, sometimes within hours to days.
For Treatment-Resistant Depression: Specifically developed for adults who haven't responded to at least two different antidepressants.
Convenient Administration: Self-administered nasal spray under the supervision of a healthcare professional.
What to Expect
Initial Consultation: Our doctors will assess your condition and determine if SPRAVATO® is right for you.
First Dose: Administered in our clinic, where you'll be monitored for about two hours.
Ongoing Treatment: Regular follow-up visits ensure safety and efficacy, with most patients continuing treatment twice a week for the first month, then weekly or every two weeks thereafter.
ACACIA’S VALUES
Our Commitment to Patients
We are committed to helping our patients find a treatment that works. Though we have had great success with conventional and accelerated TMS therapy, there still are some patients who do not respond to TMS. We’ve chosen to add SPRAVATO® to our offerings to provide another pathway to wellness and healing.
It is part of Acacia's commitment to stay on the cutting-edge towards innovation and evidence-based treatments with a scientific foundation.
Payment Options
Covering treatment costs can be an obstacle for many patients, so we offer several ways to pay for TMS therapy services.
We believe everyone should have access to better mental health treatment. Acacia’s staff also works with employers, insurance companies, and government officials to make these proven treatments more widely accessible.
Insurance Plans
TMS is covered by most insurance providers for depression. Acacia accepts most insurance plans and will work with you to determine if you are eligible.
Private Pay
Acacia has private pay options for all of our services, including TMS and Accelerated TMS. Please contact us to discuss our fees. Acacia accepts cash, check, and all major credit cards.
Financial Aid
Acacia is pleased to provide financial aid for those who would benefit from TMS but may not be eligible for insurance coverage, or do not have insurance. Please contact us for more information.
ACCEPTED INSURANCES
Standard TMS Therapy is covered by most insurance companies. If your insurance provider is not presently covering TMS, Acacia can help you negotiate with your insurance provider for reimbursement, on a case-by-case basis.
START YOUR JOURNEY
Embark on Your Journey to Better Mental Health
If you or a loved one is struggling with treatment-resistant depression, SPRAVATO® might be the breakthrough you've been waiting for. Contact us today to learn more about how SPRAVATO® can be part of your path to recovery.
FAQ
-
Clinical studies have shown that Spravato can significantly reduce symptoms of depression. Many patients experience improvement within the first 24 hours, and the benefits can continue with ongoing treatment.
-
Patients have reported significant improvement in their depressive symptoms as early as the first week of treatment with Spravato.
-
Spravato has been approved by the FDA and has undergone extensive clinical trials to evaluate its safety and efficacy. However, like all medications, it may have side effects. Common side effects include dizziness, dissociation, nausea, and headache. It's important to discuss potential risks with your healthcare provider.
-
Spravato is administered as a nasal spray under the supervision of a healthcare provider in a certified medical office or clinic. The initial phase of treatment typically involves twice-weekly dosing, which may be reduced over time based on the patient’s response.
-
If you have treatment-resistant depression and have not found relief with other antidepressants, Spravato might be a suitable option. Consult with a healthcare provider who can assess your medical history, current condition, and overall suitability for this treatment.
Research Center
Acacia Team